| #390 |
Lewilynn L. Goldfinger |
Smithkline Beecham Limited |
1 |
| #390 |
Chaya Duraiswami |
Smithkline Beecham Limited |
1 |
| #390 |
Michele Fultz |
— |
1 |
| #390 |
David A. Holly |
— |
1 |
| #390 |
Honggang Zhu |
Merck |
1 |
| #390 |
Michael Fultz |
— |
1 |
| #390 |
Robert Andrew Klink |
Henson Company |
1 |
| #390 |
Jesus Raul Medina |
Glaxosmithkline |
1 |
| #390 |
Melissa Gordon |
— |
1 |
| #390 |
Kaushik Raha |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Margaret M. Jackson |
Oracle |
1 |
| #390 |
William Arena |
— |
1 |
| #390 |
Daemon A. Heckman |
Streamlight |
1 |
| #390 |
Natalie Paige Bronk Schwab |
— |
1 |
| #390 |
Gerald Patrick Brady, Jr. |
Glaxosmithkline |
1 |
| #390 |
Shen Gu |
Scripps Research |
1 |
| #390 |
Shenshen Cai |
Glaxosmithkline |
1 |
| #390 |
Deepika Khilnaney-Chhabria |
Temple University |
1 |
| #390 |
Katharine S. PASTORE |
Arkema |
1 |
| #390 |
Laura M. Surdi |
Merck |
1 |
| #390 |
Abha A. Saini |
US Air Force |
1 |
| #390 |
Megan Ketchum |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Grace Price |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Elizabeth Ann Moroz |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Todd Koretke |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Terrence Taelim Roh |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Kevin Colizza |
US Dept of Homeland Security |
1 |
| #390 |
Aaron Tien-Hsin Cheng |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Daniel Sylvester |
Smithkline Beecham Limited |
1 |
| #390 |
Ron Rothenberger |
— |
1 |
| #390 |
Hyunjung Kim |
Onyx Pharmaceuticals |
1 |
| #390 |
Brian McGinty |
— |
1 |
| #390 |
Joel Davne |
— |
1 |
| #390 |
Kelem Kassahun |
Merck |
1 |
| #390 |
Norine McDevitt |
Hartford Fire Insurance |
1 |
| #390 |
Tyler S. Kovitch |
Fisher Clinical Services Gmbh |
1 |
| #390 |
Michal Pawel GLOGOWSKI |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Paul Mozley |
Lucerno Dynamics |
1 |
| #390 |
Denise Teotico Pohlhaus |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #390 |
Warren James Rocque |
Five Prime Therapeutics |
1 |
| #390 |
Vincent Marinelli |
Medidata Solutions |
1 |
| #390 |
Karl Ginther |
National Railroad Passenger |
1 |
| #390 |
Darryl L. Davis |
Johnson & Johnson |
1 |
| #390 |
Rebecca A Hoffman |
— |
1 |
| #390 |
Michael Peter Senderak |
— |
1 |
| #390 |
Patrick WILKINSON |
Johnson & Johnson |
1 |
| #390 |
Allison K. Dunn |
Glaxosmithkline |
1 |
| #390 |
Ren Xie |
Glaxosmithkline |
1 |
| #390 |
Michael La Salle |
Certainteed |
1 |
| #390 |
Andrew Nicholas Knox |
Glaxosmithkline |
1 |